摘要: Because of its prevalence, breast cancer is a major public health problem although prognosis has improved as result early screening and improvement in treatments. We now no longer refer to the singular, but cancers, which have different prognoses treatments depending on their molecular profile.
core.ac.uk
elsevier.com
sci-hub.se 参考文章(15)
Early Breast Cancer Trialists' Collaborative Group, None, Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. The Lancet. ,vol. 379, pp. 432- 444 ,(2012) , 10.1016/S0140-6736(11)61625-5
NANCY G. HILDRETH, JENNIFER L. KELSEY, VIRGINIA A. LIVOLSI, DIANA B. FISCHER, THEODORE R. HOLFORD, EVELYN D. MOSTOW, PETER E. SCHWARTZ, COLIN WHITE, AN EPIDEMIOLOGIC STUDY OF EPITHELIAL CARCINOMA OF THE OVARY American Journal of Epidemiology. ,vol. 114, pp. 398- 405 ,(1981) , 10.1093/OXFORDJOURNALS.AJE.A113207
Early Breast Cancer Trialists' Collaborative Group, None, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials The Lancet. ,vol. 365, pp. 1687- 1717 ,(2005) , 10.1016/S0140-6736(05)66544-0
Mitch Dowsett, Jack Cuzick, Jim Ingle, Alan Coates, John Forbes, Judith Bliss, Marc Buyse, Michael Baum, Aman Buzdar, Marco Colleoni, Charles Coombes, Claire Snowdon, Michael Gnant, Raimund Jakesz, Manfred Kaufmann, Francesco Boccardo, Jon Godwin, Christina Davies, Richard Peto, Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen Journal of Clinical Oncology. ,vol. 28, pp. 509- 518 ,(2010) , 10.1200/JCO.2009.23.1274
Jean-Philippe Jacquin, Stephen Jones, Nicolas Magné, Céline Chapelle, Paul Ellis, Wolfgang Janni, Dimitrios Mavroudis, Miguel Martín, Silvy Laporte, Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials. Breast Cancer Research and Treatment. ,vol. 134, pp. 903- 913 ,(2012) , 10.1007/S10549-011-1933-0
Nehmat Houssami, Petra Macaskill, Gunter von Minckwitz, Michael L. Marinovich, Eleftherios Mamounas, Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy☆ European Journal of Cancer. ,vol. 48, pp. 3342- 3354 ,(2012) , 10.1016/J.EJCA.2012.05.023
Jacques Estève, Incidence du cancer du sein en France et dans les pays développés Presse Medicale. ,vol. 36, pp. 315- 321 ,(2007) , 10.1016/J.LPM.2006.12.007
Wenjin Yin, Yiwei Jiang, Zhenzhou Shen, Zhimin Shao, Jinsong Lu, Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0021030
José Baselga, Ian Bradbury, Holger Eidtmann, Serena Di Cosimo, Evandro de Azambuja, Claudia Aura, Henry Gómez, Phuong Dinh, Karine Fauria, Veerle Van Dooren, Gursel Aktan, Aron Goldhirsch, Tsai-Wang Chang, Zsolt Horváth, Maria Coccia-Portugal, Julien Domont, Ling-Min Tseng, Georg Kunz, Joo Hyuk Sohn, Vladimir Semiglazov, Guillermo Lerzo, Marketa Palacova, Volodymyr Probachai, Lajos Pusztai, Michael Untch, Richard D Gelber, Martine Piccart-Gebhart, Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. The Lancet. ,vol. 379, pp. 633- 640 ,(2012) , 10.1016/S0140-6736(11)61847-3
E. Hindie, D. Groheux, I. Brenot-Rossi, D. Rubello, J.-L. Moretti, M. Espie, The Sentinel Node Procedure in Breast Cancer: Nuclear Medicine as the Starting Point The Journal of Nuclear Medicine. ,vol. 52, pp. 405- 414 ,(2011) , 10.2967/JNUMED.110.081711